非清髓性造血干细胞移植治疗老年恶性肿瘤
Treatment of nonmyeloablative stem cell transplantation for eldly patients with malignancies
摘要
老年恶性肿瘤患者常无法耐受传统大剂量放化疗预处理 ,非清髓性造血干细胞移植(NST)以免疫抑制为主 ,降低了放化疗强度 ,为不适合做传统移植的患者带来希望。
出处
《国外医学（肿瘤学分册）》
2004年第4期316-318,共3页
Foreign Medical Sciences (Cancer Section)
参考文献14
-
1ShimoniA, Andelini B, Estey E, et al. Allogeneic transplantation for leukemia in patients older than 60 years: age should not exclude treament with nonmyeloablative regime. Blood, 1999,94(Suppl 1):710a.
-
2Mc Sweeney PA, Niederwieser D, Shizura JA, et al. Molecular remission after non-myeloablative allografting for chronic myelocytic leukemia(CML). Blood, 1999,94(Suppl 1):710a.
-
3Schlenk RF, Hartmann F, Hensel M, et al. Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia. Leukemia, 2002,16(4) :581-586.
-
4KrogerN, ScheteligJ, ZabelinaT, etal. Afludarabine-based dose-reduced conditioning regimen followed by allogeneic sterm cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. Bone Marrow Transplant, 2001,28(7) :643-647.
-
5Khouri IF, Keating M, Korbling M, et al. Transplant-life: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol, 1998,16(8):2817-2824.
-
6Badros A, Barlogie B, Morris C, et al. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions. Blood, 2001,97(9):2574-2579.
-
7Badros A, Barlogie B, Siegel E, et al. Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning. J Clin Oncol, 2002,20(5): 1295-1303.
-
8Rini BI, Zimmerman T, Stadler WM, et al. Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results. J Clin Oncol,2002,20(8) :2017-2024.
-
9Childs R, Chemoff A, Contentin N, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheralblood stem-cell transplantation. N Engl J Med, 2000,343(11):750-758.
-
10Bregni M, Dodero A, Peccatori J, et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood, 2002,99(11) :4234-4236.
-
1丁家华,陈宝安,苏爱玲.非清髓性造血干细胞移植治疗慢性粒细胞白血病一例[J].江苏医药,2003,29(4):320-320.
-
2达万明.积极稳妥地开展非清髓性造血干细胞移植[J].中华医学杂志,2000,80(12):885-887. 被引量：5
-
3王顺清,毛平,李庆山,应逸,莫文健,许艳丽,王汉平,杜庆华,谢健晋.非清髓性造血干细胞移植加供者淋巴细胞输注治疗多发性骨髓瘤1例报告并文献复习*[J].临床血液学杂志,2005,18(2):75-78. 被引量：3
-
4李庆山,毛平,王顺清,莫文健,应逸,许艳丽.供者淋巴细胞输注在恶性血液病非清髓性骨髓移植中的应用[J].中华器官移植杂志,2004,25(5):308-311. 被引量：11
-
5周素贞,彭群英,邓秀云,江丽桃,李佩兰.恶性血液病非清髓性造血干细胞移植后供者淋巴细胞输注的观察及护理[J].中华临床医药杂志（北京）,2003,4(24):46-47.
-
6耿志国.非清髓性造血干细胞移植与标准移植的区别[J].实用医学进修杂志,2004,32(1):32-32.
-
7丁家华,陈宝安,董伟民,王骏,赵刚,高冲,孙耘玉,金宝翠,程坚.非清髓性外周血干细胞移植治疗慢性粒细胞白血病[J].白血病．淋巴瘤,2004,13(3):136-138. 被引量：1
-
8李庆山,毛平,王顺清,朱志刚,王汉平,许艳丽,应逸,莫文健.非清髓性移植后供者淋巴细胞输注治疗血液病的疗效观察[J].中山大学学报（医学科学版）,2004,25(6):573-576. 被引量：7
-
9商安芳,杨俊,郭静明,陈虎,岑勉发.血液肿瘤患者锁骨下静脉置管后并发深静脉血栓3例[J].临床血液学杂志,2006,19(6):374-375. 被引量：2
-
10房彤,高宏.低剂量全身照射在非清髓性干细胞移植中的临床研究[J].中华放射医学与防护杂志,2009,29(1):80-82.
